NCT07136766View on ClinicalTrials.gov

An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

February 16, 2026

Study Completion Date

February 16, 2026

Conditions
Hyperpigmentation
Interventions
DRUG

Facial Toner

Brightening Toner

OTHER

Placebo Toner

Placebo Control Toner

Trial Locations (1)

07666

Validated Claim Support, Teaneck

All Listed Sponsors
collaborator

Validated Claim Support

UNKNOWN

lead

Good Molecules, LLC

INDUSTRY